| Natural regulatory T cells control the development of atherosclerosis in mice H Ait-Oufella, BL Salomon, S Potteaux, AKL Robertson, P Gourdy, J Zoll, ... Nature medicine 12 (2), 178-180, 2006 | 1332 | 2006 |
| Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State S Fisson, G Darrasse-Jèze, E Litvinova, F Septier, D Klatzmann, R Liblau, ... The Journal of experimental medicine 198 (5), 737-746, 2003 | 645 | 2003 |
| Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia A Trenado, F Charlotte, S Fisson, M Yagello, D Klatzmann, BL Salomon, ... The Journal of clinical investigation 112 (11), 1688-1696, 2003 | 614 | 2003 |
| Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis A Ephrem, S Chamat, C Miquel, S Fisson, L Mouthon, G Caligiuri, ... Blood, The Journal of the American Society of Hematology 111 (2), 715-722, 2008 | 343 | 2008 |
| Immune infiltration in human cancer: prognostic significance and disease control WH Fridman, J Galon, MC Dieu-Nosjean, I Cremer, S Fisson, D Damotte, ... Cancer immunology and immunotherapy, 1-24, 2011 | 301 | 2011 |
| Tumor microenvironment is multifaceted C Sautès-Fridman, J Cherfils-Vicini, D Damotte, S Fisson, WH Fridman, ... Cancer and Metastasis Reviews 30, 13-25, 2011 | 153 | 2011 |
| Murine models of B‐cell lymphomas: promising tools for designing cancer therapies S Donnou, C Galand, V Touitou, C Sautès-Fridman, Z Fabry, S Fisson Advances in hematology 2012 (1), 701704, 2012 | 88 | 2012 |
| Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis S Fisson, H Ouakrim, V Touitou, S Baudet, R Ben Abdelwahed, S Donnou, ... PloS one 8 (2), e52385, 2013 | 75 | 2013 |
| Dosage thresholds and influence of transgene cassette in adeno-associated virus–related toxicity H Khabou, C Cordeau, L Pacot, S Fisson, D Dalkara Human Gene Therapy 29 (11), 1235-1241, 2018 | 71 | 2018 |
| Therapeutic potential of self‐antigen‐specific CD4+CD25+ regulatory T cells selected in vitro from a polyclonal repertoire S Fisson, F Djelti, A Trenado, F Billiard, R Liblau, D Klatzmann, JL Cohen, ... European journal of immunology 36 (4), 817-827, 2006 | 58 | 2006 |
| Induction of antigen-specific tolerance by intrathymic injection of lentiviral vectors G Marodon, S Fisson, B Levacher, M Fabre, BL Salomon, D Klatzmann Blood 108 (9), 2972-2978, 2006 | 57 | 2006 |
| ISOLD: a new highly sensitive interleukin score for intraocular lymphoma diagnosis M Costopoulos, V Touitou, JL Golmard, A Darugar, S Fisson, P Bonnemye, ... Ophthalmology 123 (7), 1626-1628, 2016 | 55 | 2016 |
| Selective expression of inhibitory Fcγ receptor by metastatic melanoma impairs tumor susceptibility to IgG‐dependent cellular response L Cassard, JFG Cohen‐Solal, EM Fournier, S Camilleri‐Broët, A Spatz, ... International journal of cancer 123 (12), 2832-2839, 2008 | 54 | 2008 |
| Preclinical study of ublituximab, a glycoengineered anti-human CD20 antibody, in murine models of primary cerebral and intraocular B-cell lymphomas RB Abdelwahed, S Donnou, H Ouakrim, L Crozet, J Cosette, A Jacquet, ... Investigative Ophthalmology & Visual Science 54 (5), 3657-3665, 2013 | 43 | 2013 |
| Bioluminescence-based tumor quantification method for monitoring tumor progression and treatment effects in mouse lymphoma models J Cosette, RB Abdelwahed, S Donnou-Triffault, C Sautès-Fridman, ... JoVE (Journal of Visualized Experiments), e53609, 2016 | 42 | 2016 |
| Cellular and molecular mechanisms of anterior chamber-associated immune deviation (ACAID): what we have learned from knockout mice J Vendomèle, Q Khebizi, S Fisson Frontiers in immunology 8, 1686, 2017 | 39 | 2017 |
| Regulatory T cells control uveoretinitis induced by pathogenic Th1 cells reacting to a specific retinal neoantigen C Terrada, S Fisson, Y De Kozak, M Kaddouri, P Lehoang, D Klatzmann, ... The Journal of Immunology 176 (12), 7171-7179, 2006 | 39 | 2006 |
| Impaired th1/tc1 cytokine production of tumor-infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma V Touitou, C Daussy, B Bodaghi, S Camelo, Y de Kozak, P Lehoang, ... Investigative ophthalmology & visual science 48 (7), 3223-3229, 2007 | 35 | 2007 |
| Treatment of uveitis by in situ administration of ex vivo–activated polyclonal regulatory T cells S Grégoire, C Terrada, GH Martin, G Fourcade, A Baeyens, G Marodon, ... The Journal of Immunology 196 (5), 2109-2118, 2016 | 32 | 2016 |
| Systemic and local immune responses to intraocular AAV vector administration in non-human primates D Ail, D Ren, E Brazhnikova, C Nouvel-Jaillard, S Bertin, SB Mirashrafi, ... Molecular Therapy-Methods & Clinical Development 24, 306-316, 2022 | 31 | 2022 |
David KlatzmannSorbonne University & Pitié-Salpêtrière Hospital在 sorbonne-universite.fr 的电子邮件经过验证
